Find Research Projects

Search results

• Answering longstanding plant ecology questions with new technology: the effects of changes in leaf proteins with age

  Westoby, M., Van Sluyter, S., Haynes, P., Gygi, S. P. & MQRES (International), M. (.

  1/01/14 → …

  Project: Research

• Antenna response of gamma-irradiated Queensland fruit flies

  Weldon, C., Collins, S. & Taylor, P.

  1/01/10 → 31/12/10

  Project: Research

• Antennas and Other Electromagnetic Components for Wireless-Enabled Complex Systems

  Esselle, K.

  12/02/11 → 29/07/11

  Project: Research

• Anthi

  Barkat, I. & Sivanathan, A.

  28/09/20 → 30/06/21

  Project: Research

• Antibiotic resistance: combining microscopy, microfluidics and genomics to target bacterial DNA repair pathways

  Robinson, A., Paulsen, I. & Jin, D.

  1/01/19 → 31/12/21

  Project: Other

• Antibiotic resistance and the ecological effects of selective decontamination of the digestive tract in Intensive Care Units

  Paulsen, I., Iredell, J., Partridge, S., Darling, A. & Seppelt, I.

  1/01/17 → …

  Project: Research

• Antimicrobial compounds from the model marsupial, the Tammar wallaby (Macropus eugenii )

  Ambatipudi, S.

  1/07/06 → 30/06/08

  Project: Research

• Ant inspired rules for self-assembly in swarm robotics and complex systems

  Reid, C.

  1/05/19 → 30/04/22

  Project: Research

• ACARP: Antiochia ad Cragum Archaeological Research Project

  Dodd, E. & Hoff, M.

  1/06/14 → …

  Project: Research

• AntiPort - Educating the Public on the risks and prevention of Mobile Number Porting Scams

  Trueck, S., Selby, J., Doche, C. & Boyd, M.

  1/02/19 → 31/12/20

  Project: Research

• USYD Lifespan Seed Grants Program: Anxiety and alcohol use during the transition to young adulthood: Can we re-train the brain?

  Prior, K., Stapinski, L., Wiers, R., Mahoney, A., Curtis, J., Salemink, E., Teachman, B., Newton, N., Teesson, M., Baillie, A., Deady, M., McLellan, L., Mewton, L. & Lees, B.

  15/04/19 → 16/12/19

  Project: Research

• Anywhere Working (Telework) and Telehealth Delivery: Productivity, Wellbeing and Service Quality

  Blount, Y., Markey, R. & Gloet, M.

  1/01/14 → 31/12/15

  Project: Research

• ENZA-P: ANZUP 1901: A randomised phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide

  Zhang, A. & Chapman, N.

  26/10/21 → 22/10/25

  Project: Research

• Aortic stiffness, Ventriculo-Arterial Coupling, Heart Mechanics and Coronary Supply: a Novel Sheep Model of Heart Failure with Preserved Ejected Fraction (HFPEF)

  Avolio, A.

  12/01/12 → 14/12/13

  Project: Research

• A PRIORI: Aortix Therapy for Perioperative Reduction of Renal Injury (A PRIORI)

  Worthley, S., Chapman, N. & Chester, C.

  9/05/22 → 28/04/27

  Project: Research

• APA PhD scholarship

  Herke, M.

  1/02/02 → 30/06/05

  Project: Research

• APECS determination of Auger parameters of C and Si

  Thurgate, S. & van Rissen, G.

  23/04/07 → 25/04/07

  Project: Research

• A perception-based intervention for body size misperception

  Stephen, I.

  8/01/18 → …

  Project: Research

• A Personalized Social Network Based Location Search and Recommender System

  Yang, J., Orgun, M., Wang, Y., Air, M., Eichhorn, B. & Rej, T.

  1/05/13 → …

  Project: Research

• APEX AMI

  Brown, M.

  Project: Research

• A Pharmacological Targeting Approach Implementing Albumin as a Carrier of a Novel Chemotherapeutic

  Lovejoy, D., Kalinowski, D., Rahmanto, Y. & Ponka, P.

  1/01/13 → 31/12/15

  Project: Research

• ADG116-1003: A Phase 1, Open-Label, Dose Escalation Study of ADG116 in Patients with Advanced/Metastatic Solid Tumors

  Park, J., Chapman, N. & Sabanathan, D.

  14/09/20 → 27/08/25

  Project: Research

• Y-biologics: A Phase 1, Open-Label, Multicenter, Single Arm, Dose-Escalation/Dose-Expansion Study of YBL-006 in Patients with Advanced Solid Tumors

  Sabanathan, D., Park, J., Gurney, H., Chapman, N. & Rai, M.

  1/06/20 → 30/04/23

  Project: Research

• CS3002-101: A phase 1, open-label, multi-dose, dose escalation and expansion study to investigate the safety, tolerability, pharmacokinetics and anti-tumor activities of CS3002, a CDK4/6 inhibitor, in subjects with advance solid tumors

  Park, J., Sabanathan, D. & Chapman, N.

  30/10/20 → 24/09/25

  Project: Research

• SBT6050-1001: A Phase 1/1b, Open Label, Dose Escalation and Expansion Study of SBT6050 in Patients with Advanced Solid Tumors Expressing HER2

  Sabanathan, D., Park, J. & Chapman, N.

  2/09/20 → 27/08/25

  Project: Research

• LYT-100-2020-01: A Phase 1/1b Multiple Ascending Dose and Food Effect Study in Healthy Volunteers to Determine the Pharmacokinetics and Maximally Tolerated Dose of Deupirfenidone (LYT-100) Followed by Further Exploration in Patients with Breast Cancer-Related Upper Limb Secondary Lymphoedema

  Mackie, H., Koelmeyer, L. A., Chapman, N. & Rai, M.

  1/08/20 → 25/06/25

  Project: Research

• AB928CSP0002: A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants with Breast or Gynecologic Malignancies

  Sabanathan, D., Kefford, R., Cunningham, J. & Butala, R.

  6/12/18 → 9/04/21

  Project: Other

• A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma

  Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.

  16/05/19 → 15/05/24

  Project: Other

• A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma

  Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.

  16/05/19 → 15/05/24

  Project: Other

• A Phase 1B, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Ipatasertib in Combination with Rucaparib in patients with Advanced Breast, Ovarian, or Prostate Cancer

  Gurney, H., Chapman, N. & Butala, R.

  5/08/19 → 26/06/24

  Project: Other

• A Phase 1B/2 study to evaluate safety and anti-tumour activity of AVELUMAB in combination with POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) inhibitor TALAZOPARIB in patients with locally advance or metastatic solid tumours

  Sabanathan, D., Kefford, R., Butala, R. & Cunningham, J.

  19/07/18 → 5/01/21

  Project: Research

• XL184-021: A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors

  Park, J., Sabanathan, D., Gurney, H., Chapman, N. & Rai, M.

  28/08/20 → 30/04/25

  Project: Research

• MT-5111_001: A Phase 1b Open-label, Multicenter Dose Escalation and Expansion Study of MT-5111 in Subjects With Previously Treated Advanced HER2-positive Solid Tumors

  Sabanathan, D., Park, J. & Chapman, N.

  13/12/21 → 12/12/26

  Project: Research

• C0541001: A PHASE 1 DOSE ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF PF 06804103 IN PATIENTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) POSITIVE AND NEGATIVEe SOLID TUMORS

  Sabanathan, D. & Chapman, N.

  21/09/20 → 31/05/25

  Project: Research

• SHR-A1811-1-101: A Phase 1 Multi-Country, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A1811 in HER2 Expressing or Mutated Advanced Malignant Solid Tumor Subjects

  Park, J. & Chapman, N.

  28/09/20 → 31/12/22

  Project: Research

• ZN-c5-002: A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with EstrogenReceptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

  Sabanathan, D., Park, J. & Chapman, N.

  15/10/20 → 23/07/21

  Project: Research

• Harbour Biomed 4003.1: A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors

  Gurney, H., Chapman, N., Butala, R., Parshionikar, A. & Rajasekharan Nair, A.

  30/09/19 → 30/09/24

  Project: Other

• HP518-CS-001: A Phase 1 open-label study to assess the safety, pharmacokinetics and anti-tumor activity of oral HP518 in patients with metastatic castration-resistant prostate cancer

  Gurney, H. & Chapman, N.

  17/01/22 → 13/12/26

  Project: Research

• MISC_Covance Chiltern: A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting Programmed Death Ligand 1 (PD-L1) Protein in Patients with Advanced Solid Tumors

  Gurney, H., Butala, R. & Cunningham, J.

  16/07/18 → 15/07/23

  Project: Other

• CYCLONE 2: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer

  Gurney, H., Chapman, N., Cunningham, J. & Butala, R.

  1/12/18 → 30/11/23

  Project: Other

• GALAXI: A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease

  Leong, R., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  30/09/19 → 7/05/24

  Project: Research

• APOLLO-CD: A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of PRA023 in Subjects with Moderately to Severely Active Crohn’s Disease

  Leong, R. & Chapman, N.

  8/02/22 → 28/07/26

  Project: Research

• VEGA: A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  Leong, R., Butala, R. & Chapman, N.

  24/09/19 → 11/07/24

  Project: Other

• A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

  Gurney, H., Cunningham, J. & Butala, R.

  17/10/18 → 4/09/23

  Project: Other

• ACT16849: A Phase 2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit of SAR444245 (THOR-707) combined with other anticancer therapies for the treatment of participants with lung cancer or pleural mesothelioma

  Park, J., Chapman, N. & Tan, P.

  13/05/21 → 15/04/26

  Project: Research

• A Phase 2 Open Label Trial of 3K3A-APC in Amyotrophic Lateral Sclerosis.

  Rowe, D., Gan, R. & Ordonez Artunduaga, P.

  Project: Research

  File

• GS-US-548-5916: A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma

  Park, J., Sabanathan, D., Xia, C. Y., Kim, S. & Chapman, N.

  3/08/21 → 29/07/26

  Project: Research

• A Phase 3, multicenter, randomized, open-label, active-controlled study of DS-8201a, an anti-HER2-antibody drug conjugate, versus treatment of investigator’s choice for HER2-positive, unresectable and/or metastatic breast cancer subjects pretreated with prior standard of care HER2 therapies, including T-DM1

  Kefford, R., Butala, R. & Cunningham, J.

  12/03/19 → 25/11/23

  Project: Other

• A phase 3, placebo controlled, doubleblind,randomized, clinical study to determine efficacy, safety and tolerability of pulsed,inhaled nitric oxid (iNO) versus placebo in symptomatic subjects with

  Brown, M. & Butala, R.

  11/11/16 → 30/09/18

  Project: Research

• ADVANCE capacity: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Recently Initiated Therapy

  Brown, M., Chapman, N., Rai, M. & Parshionikar, A.

  1/07/20 → 31/03/25

  Project: Research